KUNG ROBERT T V 4

Accession 0001179110-04-013308

CIK 0000815094other

View on SEC.gov Company Profile

Filed

Jun 17, 8:00 PM ET

Accepted

Jun 18, 5:28 PM ET

Size

23.1 KB

Accession

0001179110-04-013308

Insider Transaction Report

Form 4

Period: 2004-06-18

ABIOMED INCABMD

KUNG ROBERT T V

SVP, Chief Scientific Officer

Transactions

Sale
Common Stock, $.01 par value
2004-06-18$12.89/sh−2,253$29,046→ 0 total
Exercise/Conversion
Common Stock, $.01 par value
2004-06-18$5.31/sh+2,253$11,970→ 2,253 total
Exercise/Conversion
Stock Option (right to buy)
2004-06-18−2,253→ 11,747 total
Exercise: $5.31From: 2000-12-14Exp: 2005-12-14→ Common Stock (14,000 underlying)

Holdings

Stock Option (right to buy)
Exercise: $6.25From: 2001-08-12Exp: 2006-08-12→ Common Stock (52,500 underlying)
52,500
Stock Option (right to buy)
Exercise: $5.75From: 2002-05-27Exp: 2007-05-27→ Common Stock (10,000 underlying)
10,000
Stock Option (right to buy)
Exercise: $6.81From: 2003-07-01Exp: 2008-07-01→ Common Stock (40,000 underlying)
40,000
Stock Option (right to buy)
Exercise: $6.75From: 2004-06-25Exp: 2012-06-25→ Common Stock (50,000 underlying)
50,000
Common Stock, $.01 par value
(indirect: By Trust)
16,968
Stock Option (right to buy)
Exercise: $6.69From: 2001-07-01Exp: 2009-07-01→ Common Stock (20,000 underlying)
20,000
Stock Option (right to buy)
Exercise: $5.11From: 2005-06-25Exp: 2013-06-25→ Common Stock (16,000 underlying)
16,000
Common Stock, $.01 par value
(indirect: By Trust)
87,060
Common Stock, $.01 par value
(indirect: By Trust)
100,200

Footnotes (12)

[F1]Grant to reporting person of option to buy number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 1992 Combination Stock Option Plan.
[F10]These shares are held in trust for the benefit of the reporting person's spouse.
[F11]Thirty percent of this option will become exercisable on each of 6/25/05 and 6/25/06 and an addtional 40 percent will become exercisable on 6/25/07.
[F12]Stock was acquired and sold pursuant to a Sales Plan compliant with the requirements of SEC Rule 10b5-1.
[F2]Grant to reporting person of option to buy number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 1998 Equity Incentive Plan.
[F3]Grant to reporting person of option to buy number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2000 Stock Incentive Plan.
[F4]Options were fully exercisable on the date shown.
[F5]Thirty percent of this option will become exercisable on each of 7/1/01 and 7/1/02 and an addtional 40 percent will become exercisable on 7/1/03
[F6]Thirty percent of this option will become exercisable on each of 6/28/02 and 6/28/03 and an addtional 40 percent will become exercisable on 6/28/04.
[F7]Thirty percent of this option will become exercisable on each of 6/22/03 and 6/22/04 and an addtional 40 percent will become exercisable on 6/22/05.
[F8]Thirty percent of this option will become exercisable on each of 6/25/04 and 6/25/05 and an addtional 40 percent will become exercisable on 6/25/06.
[F9]The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for the purposes of Section 16 or for any other purposes.

Documents

1 file

4
edgar.xmlPrimary
FORM 4 -

Issuer

ABIOMED INC

CIK 0000815094

→

Entity typeother

Related Parties

filerCIK 0001203037

Filing Metadata

Form type: 4
Filed: Jun 17, 8:00 PM ET
Accepted: Jun 18, 5:28 PM ET
Size: 23.1 KB

View on SEC.gov